SCHEMBL14486355

SCHEMBL14486355

COc1ccc(Sc2ccc(Sc3ccc(OC)cc3)c([N+](=O)[O-])c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.51
MAPT P10636 8/20 0.50
PDE7A Q13946 6/20 0.50
ALDH1A1 P00352 4/20 0.50
PDE7B Q9NP56 3/20 0.50
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
NPSR1 Q6W5P4 4/20 0.47
HTT P42858 3/20 0.47
LMNA P02545 2/20 0.47
ALOX12 P18054 1/20 0.47
PDE4B Q07343 1/20 0.47
PDE4D Q08499 1/20 0.47
TXNRD1 Q16881 1/20 0.46
TXNRD3 Q86VQ6 1/20 0.46
TXNRD2 Q9NNW7 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.44
MAPK1 P28482 2/20 0.43
KDM4E B2RXH2 1/20 0.43
G6PD P11413 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL810656 0.88 TDP1 (0.58) TDP1MAPTPDE7AALDH1A1PDE7B
SCHEMBL811285 0.87 PDE7A (0.60) TDP1MAPTPDE7AALDH1A1PDE7B
SCHEMBL22208236 0.85 TDP1 (0.62) TDP1MAPTPDE7AALDH1A1PDE7B
SCHEMBL29442449 0.85 TDP1 (0.62) TDP1MAPTPDE7AALDH1A1PDE7B
SCHEMBL2960260 0.84 PDE7A (0.62) TDP1MAPTPDE7AALDH1A1PDE7B
SCHEMBL8964795 0.83 SMN1; SMN2 (0.51) TDP1MAPTPDE7AALDH1A1PDE7B
SCHEMBL1454112 0.83 HPGD (0.59) MAPTPDE7AALDH1A1MEN1KMT2A
SCHEMBL10554313 0.81 PDE7A (0.64) TDP1MAPTPDE7AALDH1A1PDE7B
SCHEMBL19048971 0.81 PDE7A (0.71) TDP1MAPTPDE7AALDH1A1PDE7B
SCHEMBL5956007 0.81 MAPT (0.52) TDP1MAPTPDE7AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013005157-A1 SULFONE DERIVATIVES AND THEIR USE AS PKM2 MODULATORS FOR THE TREATMENT OF CANCER LUPIN LIMITED (IN) 2013-01-10 WO disclosed
WO-2013005157-A1 SULFONE DERIVATIVES AND THEIR USE AS PKM2 MODULATORS FOR THE TREATMENT OF CANCER LUPIN LIMITED (IN) 2013-01-10 WO disclosed